Srinivas Akkaraju Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

Srinivas Akkaraju is Director of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 37,887 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $719,853. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

SRINIVAS AKKARAJU Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2023	SELL Disposition due to a tender of shares in a change of control transaction	$719,853 $19.0 p/Share	37,887 Reduced 100.0%	0 Common Stock
Nov 08 2023	SELL Sale (or disposition) back to the issuer	$154,109 $19.0 p/Share	8,111 Reduced 100.0%	0 Common Stock
May 24 2023	BUY Grant, award, or other acquisition	-	8,111 Added 14.99%	45,998 Common Stock
May 25 2022	BUY Grant, award, or other acquisition	-	7,737 Added 16.96%	37,887 Common Stock
May 27 2021	BUY Grant, award, or other acquisition	-	7,029 Added 18.91%	30,150 Common Stock

Also insider at

KDNY

CHINOOK THERAPEUTICS, INC. Healthcare

Director

JYAC

Jiya Acquisition Corp. Financial Services

Director

SYRS

Syros Pharmaceuticals, Inc. Healthcare

VTVT

vTv Therapeutics Inc. Healthcare

SRRK

Scholar Rock Holding Corp Healthcare

MLYS

Mineralys Therapeutics, Inc.

Director

ALMS

ALUMIS INC.